Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Future Drug Discovery|November 20, 2019
Targeting peripheral ϰ-opioid receptors for the non-addictive treatment of painTyler C Beck, Thomas A DixAdvances in Nanomedicine and Nanotechnology Research|May 2, 2022
Targeting Peripheral Kappa Opioid Receptors for the Treatment of Chronic Pain: Review ArticleTyler C Beck, Thomas A Dix, Carmela M ReichelOur Dermatology Online|January 1, 2024
Diet, sleep, and exercise in inflammatory skin diseasesShawn Afvari, Tyler C Beck, Maryia Kazlouskaya, et al.Medical Sciences (Basel, Switzerland)|September 5, 2019
Diuretic Activity of a Novel Peripherally-Restricted Orally-Active Kappa Opioid Receptor AgonistTyler C Beck, Matthew A Hapstack, Gautam S Ghatnekar, et al.Pharmaceuticals (Basel, Switzerland)|June 23, 2019
Therapeutic Potential of Kappa Opioid AgonistsTyler C Beck, Matthew A Hapstack, Kyle R Beck, et al.Journal of Visualized Experiments : Jove|June 22, 2026
Pioglitazone in Skin Fibrosis: Mechanistic Rationale and Therapeutic Potential of Pioglitazone for Scarring DermatosesNolan Steevens, Kathryn Keller, Luke Broughton, et al.Life (Basel, Switzerland)|March 29, 2023
Immunoglobulin G4-Related Disease-Associated Dermatitis with Pruritus: A Positive Response to DupilumabTyler C Beck, John Plante, India Robinson, et al.Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer DrugsTyler C Beck, Kyle R Beck, Jordan Morningstar, et al.Itch (Philadelphia, Pa.)|December 15, 2023
Kappa opioid agonists in the treatment of itch: just scratching the surface?Tyler C Beck, Elena M Wilson, Erik Wilkes, et al.European Journal of Pharmacology|May 20, 2019
Non-addictive orally-active kappa opioid agonists for the treatment of peripheral pain in ratsTyler C Beck, Carmela M Reichel, Kristi L Helke, et al.Pageof 2